Etiz, D., Erkal, H.S., Serin, M., Kucuk, B., Hepari, A., Elhan, A.H., … Cakmak, A. (2000). Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies. Oral Oncology, 36, 116–120.doi: 10.1016/S1368-8375(99)00075-5
Patient were randomized to receive sucralfate or placebo, delivered in an oral suspension with identical appearance, taste, and consistency. Patients received six 1-gram doses daily at regular intervals beginning on day one of radiation therapy (RT) and throughout RT, including weekends.
The study was conducted between December 1996 and December 1997.
This was a prospective, randomized, double-blind, placebo-controlled trial.
Sucralfate is low in cost, is easily administered, and had a similar compliance rate.